chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One hour after vaccination on Saturday got lethargic and so tired. Same the next day. Monday, the fatigue improved but Instartes to get muscle aches and stiffness. Soreness in my joints. By Wednesday evening my chest started to hurt for a few minutes and my heart rate temporarily Increased. As the days went on the symptoms became more regular. I also got extreme anxiety, a very fast heartbeat (up to 130 BPM), insomnia, sweating palms and feet, and very difficult to breathe. I couldn?t even get up to take a shower sometimes or sit up. I was admitted to the ER on I believe Tuesday the 23rd of March. This is all in the records. All tests came back normal  aside from low iron, but anemia tests came back negative. After all doctors refused to give me medication to directly treat it, I finally went to an urgent care where they gave me prednisone. It?s currently helping me. I was finally able to go for a walk today.
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 01-OCT-2015, the patient was vaccinated with ZOSTAVAX (0.67 ml, Lot#L024997, expiration date: 06-OCT-2016), which was improperly stored for 17 days (Incorrect product storage and incorrect dose administered). The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
hard golf ball size lump; red; itchy; little swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (little swelling), VACCINATION SITE MASS (hard golf ball size lump), ERYTHEMA (red) and PRURITUS (itchy) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE SWELLING (little swelling). On 15-Feb-2021, the patient experienced VACCINATION SITE MASS (hard golf ball size lump), ERYTHEMA (red) and PRURITUS (itchy). At the time of the report, VACCINATION SITE SWELLING (little swelling), VACCINATION SITE MASS (hard golf ball size lump), ERYTHEMA (red) and PRURITUS (itchy) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No relevant concomitant medications were reported.  No treatment information was provided.
On Tuesday, 1/25/22, patient came to Covid-19 Vaccination Site for his Pfizer Covid-19 booster vaccine. During assessment questions, client stated after his first Pfizer Covid-19 dose, he experienced his "throat closing" two hours after vaccination that resolved two hours later. After his second dose, client experienced "dizziness" with no SOB an hour after vaccination that resolved after an hour. Client stated he has no pertinent medical history or allergies, on no medications. Lead RN was made aware and sent a medical consult to Vaccine Operations Lead via message. Per County MD Dr., client was approved to get a Pfizer Covid-19 booster with a 30 minute observation. Vaccinator vaccinated client in Observation Room in the anti-gravity chair at 11:08 AM with Pfizer Covid-19 booster dose (LOT #: FK9729) in his left deltoid. Client experienced no complications or allergic reactions while waiting in Observation Room. Client was educated by EMT on signs and symptoms of adverse reactions and when to go to the ED/call MD. Client was also encouraged to sign-up on v-safe. EMT helped client up from anti-gravity chair and walked him out to his car where client left vaccination site with a steady gait.
dizzy; numbness on face and neck; This is a spontaneous report received from a Pfizer sponsored program Covax US Support. A contactable consumer (patient) reported for himself that the male patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Pfizer COVID-19 Vaccine), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced dizzy on an unspecified date with outcome of unknown, numbness on face and neck on an unspecified date with outcome of unknown. The clinical course was reported as follows: caller had first dose a few days ago, sees vaccine is not FDA approved, states he is dizzy, numbness on face and neck.   No follow-up attempts are needed. No further information is expected.
Within an hour of receiving 2nd dose of Pfizer Covid Vaccine, presented to emergency department reporting paresthesia in lips and in feet.
had heart stent put in; sore arm; low-grade fever; This spontaneous case was reported by a patient and describes the occurrence of CARDIAC DISORDER (had heart stent put in) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PYREXIA (low-grade fever). On 13-Jan-2022, the patient experienced CARDIAC DISORDER (had heart stent put in) (seriousness criterion medically significant). The patient was treated with CLOPIDOGREL BISULFATE (PLAVIX) in January 2022 at an unspecified dose and frequency and Surgery (Patient had Stent Placement) for Cardiac disorder. At the time of the report, CARDIAC DISORDER (had heart stent put in), PAIN IN EXTREMITY (sore arm) and PYREXIA (low-grade fever) outcome was unknown.            No concomitant medications were reported.  It was reported that patient had gotten all Moderna shots and received the 1st booster dose of Moderna Covid-19 vaccine (Monovalent).  Company Comment: This is a spontaneous case concerning  a  67-year-old, male patient with no reported medical history, who experienced the unexpected serious (medically significant) event of Cardiac disorder and unexpected non-serious event of Pain in extremity and expected non-serious event of Pyrexia. The events Pain in extremity and Pyrexia occurred on the same day after the unspecified dose of mRNA-1273 Vaccine. The event Cardiac Disorder occurred 59 days after the unspecified dose of mRNA-1273 Vaccine. Patient was treated with Clopidogrel and Surgery. No further details on clinical course, lab test results were reported. Outcome of the events was unknown. The benefit-risk relationship of mRNA-1273 Vaccine, is not affected by this report.   This case was linked to MOD-2022-662515 (Patient Link).; Sender's Comments: This is a spontaneous case concerning  a  67-year-old, male patient with no reported medical history, who experienced the unexpected serious (medically significant) event of Cardiac disorder and unexpected non-serious event of Pain in extremity and expected non-serious event of Pyrexia. The events Pain in extremity and Pyrexia occurred on the same day after the unspecified dose of mRNA-1273 Vaccine. The event Cardiac Disorder occurred 59 days after the unspecified dose of mRNA-1273 Vaccine. Patient was treated with Clopidogrel and Surgery. No further details on clinical course, lab test results were reported. Outcome of the events was unknown. The benefit-risk relationship of mRNA-1273 Vaccine, is not affected by this report.
Redness, irritation, swelling, and pain around injection site on L deltoid where Tdap and Gardasil was given. Also had rash on L side of face which itched.
covid-19; covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 30Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 51 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Crohn's" (unspecified if ongoing), notes: Other medical history: Crohn's. There were no concomitant medications. Past drug history included: Diclofenac, reaction(s): "Known allergies: Diclofenac". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment; Negative, notes: Full return on symptoms after having tested negative for 6 days. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Rebound infection beginning on 01Jun. Full return on symptoms after having tested negative for 6 days. Patient was treated with Anti-viral from 21May2022 to 25May2022 for Covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
fatigue, brain fog, mild headaches, serious TMJ - Jaw - left side only (same side as vaccine in left arm)
pt vax on 8/12/98, subsequently laboratory evaluation revealed the pt failed to seroconvert.
It was discovered the vaccine was not diluted resulting in a higher concentration of a dose of the pediatric vaccine. no adverse effects were observed
Patient reports 7hrs after Pfizer booster that she noticed a red circle and some inflammation and pain to upper arm area . Approx. 3 finger widths from acromion process... No itching no anaphylaxis. Still 2 days later area present with redness more spread out still localized 1.5 in size appr noted to be faded on all edges. Some tenderness to area noted. Some warmness but no streaking. Patient reports feeling completely fine. Discussed close monitoring.
Systemic: Nausea-Severe, Additional Details: patient states she developed nausea and motion sickness shortly following the second Pfizer Covid vaccine dose that is still continuing as of 5/9/21
2NOV92 pt recvd flu shot lot# 4928285 which devel into a red, edematous, warm area on rt deltoid; this began on 4NOV92 pt called office & came in for check up on 6NOV92; dx local reaction to flu shot; t98.3, p80, BP 160/98 on 6NOV92;
2 hours post injection  moderate swelling from shoulder to mid arm, throat felt "funny". Took Benadryl 25 mg q 6 hours for 18-24 hours. Reported hoarse voice by someone else.
According to the Urgent Doctor, I had an adverse reaction to the flu shot given on 11/1 which activated my eczema which in turn I developed a topical dermatitis. I developed rash on my back, cheeks, hands, arms, and thighs. It was itchy, red and angry. My face and right hand only swelled up. I was prescribed 7 days of oral pill Prednisone.
pt vax hepta B.  11jul90.  lab tests on 08aug90 revealed sgpt 138 and sgot 58, which was a change from prevaccination liver function tests on 08feb89 which revealed serum alkaline phosphatase 114, sgot 41, sgpt 86, and ldh 216.  see worm
Patient presented to the hospital for worsening SOBx 2 days.  XR Chest 1V [Auth (Verified)] (01/25 1916): FINAL IMPRESSION: Scarring or atelectasis in the left lung.  T: 97.8 °F  TMIN: 97.8 °F  TMAX: 101.3 °F  HR: 75  RR: 21  BP: 132/84  SpO2: 97%  WT: 85.1 kg  BMI: 29.45.  Patient treated for Pulmonary embolism, acute kidney injury, Discharged 2/12/22. Previously vaccinated with Moderna 2/26/21 & 3/26/21
Information has been received from a health professional concerning a 7 year old male with peanut allergy and a history of mild asthma who was vaccinated with 0.5 ml subcutaneous doses of varicella virus vaccine live (Oka/Merck) on 07-FEB-2001 and 18-SEP-2007 (Lot# 658184/1094U). There was no concomitant medication. "About 3 weeks ago", on approximately 30-JAN-2008, symptoms of a rash began and two days ago, on 03-MAR-2008, a second rash developed. The rash was determined to be chickenpox. Rashes were described as vesicular and pustular lesions. At the time of the report the patient was seen in the office. No product quality complaint was involved. No other information was provided. This is  one of several reports from the same source. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/16/2008. Additional information is not expected.
Patient complained of lightheadedness, no chest pain, no shortness of breath, no weakness. Vital signs normal. Physical exam normal. Patient allowed to rest supine for 20 minutes. Vital signs and physical exam rechecked, both normal. Patient allowed to leave with strict instructions to return if symptoms returned.
Extreme dehydration/thirst since the injection.  I have been drinking 18 (8 oz  each) glasses of water a day.  As a result, I have had a headache that won't go away.
PATIENT'S WIFE SAID HER HUSBAND RECEIVED BOOSTRIX  VACCINE AT OUR PHARMACY 06/16/2021 AND ABOUT 12 HOURS LATER PT STARTED HAVING CHEST PAINS, AND LOOKED PALE. SHE TOOK HIM TO THE HOSPITAL WHERE HE PASSED AWAY. SHE SAID THE LISTED ON THE PAPERWORK, CAUSE OF DEATH WAS "COMPLETE ORGAN FAILURE AND MYOCARDIAL INFARCTION. SHE WAS CONCERNED ABOUT THE TIMING OF HIS MEDICAL EMERGENCY AND HIS BOOSTRIX DOSE AND WISHED IT TO BE REPORTED.
This case involves a 12-years-old female patient who received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] (wrong product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications, and family history were not provided. On 19-Oct-2021, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot QFAA2136, expiry date: 30-Jun-2022) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual medication error due to wrong product administered. (Latency: same day). At time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
something deltoid bursa or something; Initial information was received on 25-Feb-2020 regarding an unsolicited valid non-serious case from other health professional.  This case involves female patient who experienced something deltoid bursa or something (bursa disorder), while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  Medical history, medical treatments, vaccinations and family history were not provided.  On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious something deltoid bursa or something (bursa disorder) (unknown latency), following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Laboratory data was not provided.  Final diagnosis was (unspecified) bursa disorder.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.  Information on batch number was requested.
Patient was diagnosed with pertussis 3/10 despite receiving Tdap vaccine 1/08.
vaccination site area started itching; Given (unknown dose) sub-cutaneous injection; left arm was sore; vaccination site "pinched" rasied bump that gradually grew darker red and then became hard; vaccination site "pinched" rasied bump that gradually grew darker red and then became hard; A spontaneous report was received from a consumer concerning a 42-year-old female, who received Moderna's COVID-19 vaccine and experienced given (unknown dose) sub-cutaneous injection, left arm was sore, pinched" raised bump, bump gradually grew darker red and area started itching.  The patient's medical history includes allergies to sulfa drugs and shellfish. No relevant concomitant medications were reported.  On 06-JAN-2021, patient received first of the two planned doses of Moderna covid-19 vaccine (Lot#011J20A) on her left arm by subcutaneous route. It was given on the back of flabby part of the arm. Her left arm became sore after the injection and in couple of hours she noticed a "pinched" raised bump on the vaccination site. It gradually grew darker red  and became hard. It lasted for 10 days. After 10 days, the area started itching which lasted for 1 week. No treatment medications were used.   On 03-FEB-2021, she received the second dose  (Lot#042L20A) intramuscularly on her left deltoid.  Action taken with Moderna Covid-19 vaccine was not applicable as patient already received two doses of vaccine.  The outcome of the events pain in extremity, vaccination site induration, vaccination site erythema, vaccination site pruritus was considered resolved on an unknown date and Incorrect route of product administration was considered resolved on 06-JAN-2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
fatigue; fever; This case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fatigue and fever. On an unknown date, the outcome of the fatigue and fever were not recovered/not resolved.   It was unknown if the reporter considered the fatigue and fever to be related to Shingrix.  Additional details were provided as follows:  The case reported by patient herself. The age at vaccination was not reported but was captured as an adult as per vaccine indication. The patient experienced fever and fatigue after shingrix dose.
1/18 10pm started with chills then fever 1/19 not feeling right 8am chills 10am fever 101.1 severe nausea near vomiting severe fatigue had fever all night 11/20 diarrhea put no fever
Pt. came in 2 days after administration complaining of rash and mild pruritus. Said she had itching about an  hour after administration but went away. Rash was about 3 inches wide by 6 inches long, advised her to take BENADRYL and to f/u with MD if does not improve.
got up to go to the bathroom in the middle of the night - felt slightly nauseated but did not vomit, also felt off balance.  Fainted while leaving the room, fell backward and hit my head, elbow, and shoulder on the door frame. My husband heard the fall, and when he came to see what happened I was unresponsive. Took several minutes for me to regain consciousness. Have a large bump/bruise on the right side of my skull, above the right ear, a bruise on my right shoulder, and a bruise, abrasion and bump on my right elbow.
After second shot extremely strong metallic taste in mouth almost immediately following injection.  Lasted about 10 hours.  Blood work in August showed my liver enzymes are elevated.
pinpoint type rash appears 24hr p/vax;generalized body & extremities;
Left Arm (shoulder) started hurting the night I got the shot. And it has continued to hurt and cause muscle pain in the same area over 5 months later. The pain hasn't stopped.
Patient stated he experienced swelling of the thyroid gland after he had received vaccine. He did not specify time frames.
Approximately 12 hours after receiving vaccine dose, I woke with chills and uncontrollable shaking/shivering. Following this, I experienced headache, body aches, fatigue and a fever that was as high as 102.0.  These symptoms were consistent over the 36 hour period following the onset of symptoms.  I slept most of the first 30 hours with symptoms.  After about 36 hours, my symptoms began to disappear and  I felt well enough to go about my regular activities.
Donor immediately complained of nausea, lightheadedness, and dizziness following Tetanus Immunization. Donor was cool, pale and diaphoretic. Donor also reports feeling very warm. Ice pack given to donor, and donor placed in supine postion. Approx recovery time was 15 min. Donor skin now pink, warm and dry. Donor's blood pressure raised to 94/60 with heart rate of 70. Donor reported feeling much better and left the center in private vehicle.
3 members of my family who had heart problems after taking the vaccines; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  An elderly male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization serious complete, unknown manufacturer), for COVID-19 Immunization. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "3 members of my family who had heart problems after taking the vaccines".  Additional information: The reporter mentioned that these vaccines are dangerous according to the news and it can be seen that all the healthy people are dying from heart failure. The reporter had 3 members of the family who had heart problems after taking the vaccines.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300014688 same reporter/vaccine/event, different patient;US-PFIZER INC-202300034771 same reporter/vaccine/event, different patient;
I don't know if I hallucinated that or not; I feel like I am on drugs like I on 'some acid'; my vision is blurry and it's kind of hard to concentrate on television; hard to concentrate; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported)\ via an unspecified route of administration on 09Mar2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation. Medical history included mental issues since 1988. The patient stated "I am calling about an adverse reaction to the second Pfizer shot. If you guys have anybody called in and find out if anybody is having the same. After the second shot, about a day after the shot, it was terrible. I got the shot last Tuesday and I feel like I am on drugs like I on 'some acid' (not clarified). But I am not hallucinating, I am not seeing things, I am not hearing things, I just physically feel that way. Everything is kind of blurry, my vision is blurry and it's kind of hard to concentrate on television and stuff like that. It seems like some people are playing mind games with it but I don't think they have (further clarification unknown, hence not captured as event). I don't know if I hallucinated that or not (consumer was not sure). That's pretty much here I feel like I am on drugs constantly and it is just kind of scary. I have mental issues since 1988, I take psych meds but it seems whenever I take my psych meds (unspecified medications) I feel worst for couple of hours." Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.